Neuropsychological aspects and mood profiles of patients with COVID-19: results of a preliminary case-control study with Brazilian participants
Main Article Content
Abstract
Background: The long-term effects of COVID-19 became a target of investigation in the years following the spread of the SARS-CoV-2 virus. The current evidence is mixed and includes studies suggesting an impairment in psychological, neuropsychological, and mood conditions, while other studies have failed to find significant differences.
Aim: We compared the cognitive and mood profiles of patients who had COVID-19 with a control group using neuropsychological measures and self-reported questionnaires.
Methodology: We implemented a case-control study from September 2021 to June 2022. We conducted an in-person neuropsychological evaluations of 45 patients who had COVID-19 and a control group of 16 participants, matching them for age, sex, education, and civil status. We evaluated their perception, attention, memory, and mood profiles. We used one-sided T-tests to check the plausibility of the hypothesis of worse results in the group of patients who had COVID-19 and we implemented a chi-squared test to assess the percentage of participants at risk for depression and anxiety in both groups.
Results: We found no significant differences on either the cognitive tests or mood profile.
Conclusion: Although preliminary, the data suggest that people who had COVID-19 have similar cognitive skills and mood profiles compared to a control group. Further research is important, given the mixed results published in the scientific literature.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Raveendran A V., Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869-875. doi:10.1016/J.DSX.2021.04.007
3. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. doi:10.1016/J.BBI.2021.12.020
4. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627. doi:10.1016/S2215-0366 (20)30203-0
5. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-754. doi:10.1080/23744235.2021.1924397
6. Orrù G, Bertelloni D, Diolaiuti F, et al. Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms. Healthcare (Basel).2021;9(5).doi:10.3390/HEALTHCARE9050575
7. Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin Neurosci. 2023;77(2):84-93. doi:10.1111/PCN .13508
8. Wild CJ, Norton L, Menon DK, Ripsman DA, Swartz RH, Owen AM. Disentangling the cognitive, physical, and mental health sequelae of COVID-19. Cell Rep Med. 2022;3(10). doi:10.1016/J.XCRM.2022.100750
9. Zawilska JB, Kuczyń ska K. Psychiatric and neurological complications of long COVID. J Psychiatr Res. 2022;156:349-360. doi:10.1016 /J.JPSYCHIRES.2022.10.045
10. Ahmad MS, Shaik RA, Ahmad RK, et al. “LONG COVID”: an insight. Eur Rev Med Pharmacol Sci. 2021;25(17):5561-5577. doi: 10.26355/EURREV_202109_26669
11. Pihlaja RE, Kauhanen LLS, Ollila HS, et al. Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. 2023;27. doi:10.1016/J.BBIH.2023.100587
12. Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinical Medicine. 2021;31. doi:10.1016/J.ECLINM. 2020.100683
13. Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A, et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40-46. doi:10.1016/J. JPSYCHIRES.2022.03.033
14. Ortelli P, Ferrazzoli D, Sebastianelli L, et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci. 2021;420. doi:10.1016/J.JNS. 2020.117271
15. Holm H, Ivarsdottir E V., Olafsdottir T, et al. Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control study. Communications Medicine. 2023;3(1):94-94. doi:10.1038/S438 56-023-00326-5
16. Zhou H, Lu S, Chen J, et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98-102. doi:10.1016/J.JPSYCHIRES.2020.06.022
17. Cian V, De Laurenzis A, Siri C, Gusmeroli A, Canesi M. Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample. Front Psychol. 2022;13. doi:10.3389/FPSYG.2022.908363
18. Woo MS, Malsy J, Pöttgen J, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2(2). doi:10.1093/BRAINCOMMS/FCAA205
19. Demir B, Beyazyüz E, Beyazyüz M, Çelikkol A, Albayrak Y. Long-lasting cognitive effects of COVID-19: is there a role of BDNF? Eur Arch Psychiatry Clin Neurosci. 2023;273(6):1339-1347. doi:10.1007/S00406-022-01514-5
20. Akıncı B, Oğ ul ÖE, Hanoğ lu L, et al. Evaluation of cognitive functions in adult individuals with COVID-19. Neurol Sci. 2023;44(3):793-802. doi:10.1007/S10072-022 -06562-2
21. Invernizzi A, Renzetti S, van Thriel C, et al. Covid-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study. medRxiv. 2023;(COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv). doi:10.1101/2023.07. 19.23292909
22. Mlinarić A, Horvat M, Smolčić VŠ. Dealing with the positive publication bias: Why you should really publish your negative results. Biochem Med (Zagreb). 2017;27(3). doi:10.11 613/BM.2017.030201
23. Nair A. Publication bias - Importance of studies with negative results! Indian J Anaesth. 2019;63(6):505. doi:10.4103/IJA.IJA_142_19
24. Paula JJ, Paiva GC de C, Costa D de S. Use of a modified version of the switching verbal fluency test for the assessment of cognitive flexibility. Dementia e Neuropsychologia. 2015; 9(3):258-264. doi: 10.1590/1980-57642015DN93000008
25. Oliveira M da S, Rigoni M dos S, Rey A. Figuras Complexas de Rey Teste de Cópia e de Reprodução de Memória de Figuras Geométricas Complexas. 2nd ed. Pearson Clinical; 2018.
26. Martins MR, Bolognani SAP, Pompéia S, Bueno OFA, Miranda MC. Versões Alternativas do Subteste Memória Lógica da WMS-R: Análise de Desempenho de uma Amostra Saudável da Cidade de São Paulo. Psicologia: Reflexão e Crítica. 2015;28(3):444-453. doi:10.1590/1678-7153.201528303
27. Nitrini R, Lefèvre BH, Mathias SC, et al. Testes neuropsicológicos de aplicação simples para o diagnóstico de demência. Arq Neuropsiquiatr. 1994;52(4):457-465. doi:10.1 590/S0004-282X1994000400001
28. Alves L, Morávia CB, de Paula JJ, Campos AF. Teste de Organização Visual Hooper e Teste de Avaliação de Habilidade Visuoespacial (THALVES). In: Avaliação Neuropsicológica. Artmed; 2010:412-425.
29. Wechsler D, Trentini C, Yates D, Heck V. WASI - Escala Wechsler Abreviada de Inteligência - Manual. 1st ed. Pearson Clinical; 2018.
30. Fioravanti-Bastos ACM, Cheniaux E, Landeira-Fernandez J. Development and validation of a short-form version of the Brazilian state-trait anxiety inventory. Psicologia: Reflexão e Crítica. 2011;24(3):485-494. doi:10.1590/S0102-79722011000300009
31. Anunciação L, Caregnato M, da Silva FSC. Aspectos psicométricos do Inventário Beck de Depressão-II e do Beck Atenção Primária em usuários do Facebook. J Bras Psiquiatr. 2019;68(2):83-91. doi:10.1590/0047 -2085000000231
32. Krishnan K, Miller AK, Reiter K, Bonner-Jackson A. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19. Arch Clin Neuropsychol. 2022;37(4):729-737. doi:10.10 93/ARCLIN/ACAC004
33. Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive Impairment After COVID-19-A Review on Objective Test Data. Front Neurol. 2021;12. doi:10.3389/FNEUR.2021.699582
34. Damiano RF, Rocca CC de A, Serafim A de P, et al. Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Front Immunol. 2023;14:1174020-1174020. doi:10. 3389/FIMMU.2023.1174020
35. Haidar MA, Jourdi H, Haj Hassan Z, et al. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist. 2022;28(6):552-571. doi:10.11 77/1073858420984106
36. Filho NH. Medida psicológica: o debate entre as perspectivas conceituais representacionista e realista. Aval psicol. 2014;13(3):399-408. Accessed January 24, 2024. http://pepsic.bvsalud.org/scielo.php?script=sci_abstract&pid=S1677-04712014000300012&lng=en&nrm=iso&tlng=pt